Tapewire

Nasdaq · USD

BLFS

BIOLIFE SOLUTIONS INC

Export transactions ↓
Tapewire entity
4614
SEC CIK
0000834365
Parsed reports
1,001

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202508
Jan 202605
Feb 202600
Mar 202609
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2023 Filed Oct 10, 2023 21:27 UTC
DuRoss AmyDirector
GrantCommon Stock 437 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-034209 · wk-form4_1696973241.xml · nonDerivative · entry 1

DuRoss Amy · CIK 0001854968 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,781

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant.

Read SEC document
October 01, 2023 Filed Oct 10, 2023 21:27 UTC GrantCommon Stock 445 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-034208 · wk-form4_1696973227.xml · nonDerivative · entry 1

Schick Joseph C · CIK 0001592238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,081

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant.

Read SEC document
October 01, 2023 Filed Oct 10, 2023 21:27 UTC GrantCommon Stock 422 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-034207 · wk-form4_1696973215.xml · nonDerivative · entry 1

GOSWAMI JOYDEEP · CIK 0001533115 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,269

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant.

Read SEC document
October 01, 2023 Filed Oct 10, 2023 21:26 UTC GrantCommon Stock 362 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-034206 · wk-form4_1696973203.xml · nonDerivative · entry 1

Ellingson Rachel · CIK 0001557271 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,190

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant.

Read SEC document
October 01, 2023 Filed Oct 10, 2023 21:26 UTC GrantCommon Stock 362 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-034205 · wk-form4_1696973193.xml · nonDerivative · entry 1

DE GREEF RODERICK · CIK 0001241181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,262

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant.

Read SEC document
October 01, 2023 Filed Oct 10, 2023 21:26 UTC GrantCommon Stock 362 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-034204 · wk-form4_1696973174.xml · nonDerivative · entry 1

MOORE TIMOTHY L. · CIK 0001669207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,138

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant.

Read SEC document
September 28, 2023 Filed Oct 2, 2023 21:08 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 568 $14.16 $8,042.88
Disclosure

SEC source: 0001628280-23-033511 · wk-form4_1696280929.xml · nonDerivative · entry 2

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,767

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 28, 2023 Filed Oct 2, 2023 21:07 UTC
Rice MichaelDirector · Chief Executive Officer
SaleCommon Stock 831 $14.16 $11,766.96
Disclosure

SEC source: 0001628280-23-033507 · wk-form4_1696280818.xml · nonDerivative · entry 2

Rice Michael · CIK 0001389512 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 418,635

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 28, 2023 Filed Oct 2, 2023 21:04 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 659 $14.16 $9,331.44
Disclosure

SEC source: 0001628280-23-033504 · wk-form4_1696280655.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 273,121

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 28, 2023 Filed Oct 2, 2023 20:56 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 464 $14.16 $6,570.24
Disclosure

SEC source: 0001628280-23-033496 · wk-form4_1696280188.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,014

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 24, 2023 Filed Oct 2, 2023 21:08 UTC
Foster Karen A.Chief Quality Officer
GrantCommon Stock 260 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-033511 · wk-form4_1696280929.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,335

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
September 24, 2023 Filed Oct 2, 2023 21:07 UTC
Rice MichaelDirector · Chief Executive Officer
GrantCommon Stock 290 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-033507 · wk-form4_1696280818.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 419,466

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
September 24, 2023 Filed Oct 2, 2023 21:04 UTC
Mathew Aby J.EVP & Chief Scientific Officer
GrantCommon Stock 802 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-033504 · wk-form4_1696280655.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 273,780

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
September 24, 2023 Filed Oct 2, 2023 21:02 UTC
Wichterman TroyChief Financial Officer
GrantCommon Stock 290 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-033502 · wk-form4_1696280531.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,590

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
September 24, 2023 Filed Oct 2, 2023 20:58 UTC
Phillips GeraintSVP, Global Operations
GrantCommon Stock 221 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-033499 · wk-form4_1696280285.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,995

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
September 21, 2023 Filed Sep 25, 2023 20:57 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 539 $12.70 $6,845.30
Disclosure

SEC source: 0001628280-23-032947 · wk-form4_1695675448.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,300

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-19-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 10, 2023 Filed Sep 12, 2023 20:49 UTC
Phillips GeraintSVP, Global Operations
GrantCommon Stock 328 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-032091 · wk-form4_1694551753.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,774

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
September 10, 2023 Filed Sep 12, 2023 20:48 UTC
Wichterman TroyChief Financial Officer
GrantCommon Stock 408 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-032090 · wk-form4_1694551695.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,839

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
September 10, 2023 Filed Sep 12, 2023 20:47 UTC
Mathew Aby J.EVP & Chief Scientific Officer
GrantCommon Stock 792 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-032089 · wk-form4_1694551660.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,978

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
September 10, 2023 Filed Sep 12, 2023 20:47 UTC
Rice MichaelDirector · Chief Executive Officer
GrantCommon Stock 1,022 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-032088 · wk-form4_1694551634.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 419,176

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
September 10, 2023 Filed Sep 12, 2023 20:46 UTC
Foster Karen A.Chief Quality Officer
GrantCommon Stock 330 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-032087 · wk-form4_1694551604.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,075

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
August 27, 2023 Filed Aug 30, 2023 21:39 UTC
Phillips GeraintSVP, Global Operations
GrantCommon Stock 401 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-031007 · wk-form4_1693431566.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,446

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
August 27, 2023 Filed Aug 30, 2023 21:39 UTC
Wichterman TroyChief Financial Officer
GrantCommon Stock 498 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-031006 · wk-form4_1693431531.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,431

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
August 27, 2023 Filed Aug 30, 2023 21:38 UTC
Mathew Aby J.EVP & Chief Scientific Officer
GrantCommon Stock 966 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-031005 · wk-form4_1693431505.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,186

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
August 27, 2023 Filed Aug 30, 2023 21:38 UTC
Rice MichaelDirector · Chief Executive Officer
GrantCommon Stock 1,248 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-031004 · wk-form4_1693431476.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 418,154

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
August 27, 2023 Filed Aug 30, 2023 21:37 UTC
Foster Karen A.Chief Quality Officer
GrantCommon Stock 403 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-031003 · wk-form4_1693431453.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,745

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
August 25, 2023 Filed Aug 29, 2023 21:54 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 347 $10.99 $3,813.53
Disclosure

SEC source: 0001628280-23-030917 · wk-form4_1693346070.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,097

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 25, 2023 Filed Aug 29, 2023 21:53 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 519 $10.99 $5,703.81
Disclosure

SEC source: 0001628280-23-030916 · wk-form4_1693346023.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 271,220

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 25, 2023 Filed Aug 29, 2023 21:53 UTC
Rice MichaelDirector · Chief Executive Officer
SaleCommon Stock 1,729 $10.99 $19,001.71
Disclosure

SEC source: 0001628280-23-030915 · wk-form4_1693345983.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 416,906

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 25, 2023 Filed Aug 29, 2023 21:52 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 410 $10.99 $4,505.90
Disclosure

SEC source: 0001628280-23-030914 · wk-form4_1693345930.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,342

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 25, 2023 Filed Aug 29, 2023 21:51 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 585 $10.99 $6,429.15
Disclosure

SEC source: 0001628280-23-030912 · wk-form4_1693345863.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,933

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 25, 2023 Filed Aug 29, 2023 21:50 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 347 $10.99 $3,813.53
Disclosure

SEC source: 0001628280-23-030911 · wk-form4_1693345803.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,478

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 25, 2023 Filed Aug 29, 2023 21:49 UTC
Phillips GeraintSVP, Global Operations
SaleCommon Stock 179 $10.99 $1,967.21
Disclosure

SEC source: 0001628280-23-030910 · wk-form4_1693345751.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,045

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 25, 2023 Filed Aug 29, 2023 21:48 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 347 $10.99 $3,813.53
Disclosure

SEC source: 0001628280-23-030909 · wk-form4_1693345657.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,532

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 20:48 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 180 $12.38 $2,228.40
Disclosure

SEC source: 0001628280-23-029686 · wk-form4_1692218906.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 271,739

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 20:49 UTC
Rice MichaelDirector · Chief Executive Officer
SaleCommon Stock 277 $12.38 $3,429.26
Disclosure

SEC source: 0001628280-23-029688 · wk-form4_1692218968.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 418,635

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 20:49 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 108 $12.38 $1,337.04
Disclosure

SEC source: 0001628280-23-029687 · wk-form4_1692218936.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,444

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 20:48 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 134 $12.38 $1,658.92
Disclosure

SEC source: 0001628280-23-029685 · wk-form4_1692218881.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,825

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 20:47 UTC
Phillips GeraintSVP, Global Operations
SaleCommon Stock 109 $12.57 $1,370.13
Disclosure

SEC source: 0001628280-23-029684 · wk-form4_1692218854.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,224

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 20:47 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 94 $12.57 $1,181.58
Disclosure

SEC source: 0001628280-23-029683 · wk-form4_1692218830.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,518

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 20:46 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 156 $12.38 $1,931.28
Disclosure

SEC source: 0001628280-23-029682 · wk-form4_1692218805.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,752

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 20:46 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 104 $12.38 $1,287.52
Disclosure

SEC source: 0001628280-23-029681 · wk-form4_1692218782.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,879

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 09, 2023 Filed Aug 11, 2023 21:01 UTC
Casdin Eli10% owner
PurchaseCommon Stock, par value $.001 per share 58,465 $13.20 $771,743.85
Disclosure

SEC source: 0000919574-23-004543 · ownership.xml · nonDerivative · entry 1

Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner

Casdin Capital, LLC · CIK 0001534261 · 10% owner

Casdin Partners GP, LLC · CIK 0001534260 · 10% owner

Casdin Eli · CIK 0001534264 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,630,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $13.1151 to $13.3998. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F2 · ownership.direct: The securities are owned directly by the Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Read SEC document
July 24, 2023 Filed Jul 26, 2023 22:09 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 679 $19.50 $13,240.50
Disclosure

SEC source: 0001628280-23-025784 · wk-form4_1690409364.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,552

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
July 24, 2023 Filed Jul 26, 2023 22:08 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 462 $19.50 $9,009.00
Disclosure

SEC source: 0001628280-23-025783 · wk-form4_1690409329.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,983

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
July 20, 2023 Filed Jul 24, 2023 20:35 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001628280-23-025476 · wk-form4_1690230904.xml · derivative · entry 6

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
July 20, 2023 Filed Jul 24, 2023 20:35 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $20.07 $200,700.00
Disclosure

SEC source: 0001628280-23-025476 · wk-form4_1690230904.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 271,919

F2 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.17, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 20, 2023 Filed Jul 24, 2023 20:35 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001628280-23-025476 · wk-form4_1690230904.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 281,919

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 19, 2023 Filed Jul 24, 2023 20:35 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001628280-23-025476 · wk-form4_1690230904.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
July 19, 2023 Filed Jul 24, 2023 20:35 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $20.46 $204,600.00
Disclosure

SEC source: 0001628280-23-025476 · wk-form4_1690230904.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 271,919

F2 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.24 to $20.84, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.